Thrombotic Disorders with Increased Levels of Antiplasmin and Antiplasminogen
- 2 November 1961
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 265 (18) , 867-871
- https://doi.org/10.1056/nejm196111022651801
Abstract
DESPITE recent advances in the understanding of hemostasis the cause of many thrombotic disorders has not been established. Thrombosis is probably the common expression of diverse etiologies, some originating in the vascular wall, others in the intrinsic coagulation mechanism and still others in extravascular disturbances. Among these possibilities an increased inhibition of normal clot lysis has been described as a cause of abnormal thrombi.1 2 3 4 Although a number of such inhibitors have been reported,5 6 7 8 to date they have been thought significant chiefly as factors that may complicate fibrinolytic therapy. Only a few reports have noted increased levels of such inhibitors in . . .Keywords
This publication has 17 references indexed in Scilit:
- Reduced Fibrinolytic Activity of Atherosclerotic Sera caused by an Increase in Low-density Lipoproteins in BloodNature, 1961
- Experiences with inhibitors to the plasmin-plasminogen system in the human subjectThe American Journal of Cardiology, 1960
- Spontaneous fibrinolysis∗The American Journal of Cardiology, 1960
- FIBRINOLYTIC ACTIVITY OF THE BLOOD IN INTERMITTENT CLAUDICATIONThe Lancet, 1959
- THE MECHANISM OF CLOT DISSOLUTION BY PLASMIN*Journal of Clinical Investigation, 1959
- The Fibrinolytic Enzyme System in Normal, Hemorrhagic and Disease States1Journal of Clinical Investigation, 1958
- Plasma Thromboplastin Component: Influence of Coumarin Compounds and Vitamin K on Its Activity in SerumExperimental Biology and Medicine, 1956
- STUDIES ON THE INHIBITION OF PROTEOLYTIC ENZYMES BY SERUMThe Journal of Experimental Medicine, 1952
- A STUDY OF ANTIFIBRINOLYSIN ACTIVITY IN THE PLASMAS OF VARIOUS ANIMAL SPECIES 1Journal of Clinical Investigation, 1948